Post-transplant, eGFR impacts cardio risk independently

Post-Transplant, eGFR impacts cardio risk independently
In stable kidney transplant recipients, kidney function, as determined by estimated glomerular filtration rate, is independently associated with cardiovascular events and death, according to research published online May 17 in the American Journal of Transplantation.

(HealthDay) -- In stable kidney transplant recipients, kidney function, as determined by estimated glomerular filtration rate (eGFR), is independently associated with cardiovascular (CVD) events and death, according to research published online May 17 in the American Journal of Transplantation.

Daniel E. Weiner, M.D., of Tufts Medical Center in Boston, and colleagues conducted a post hoc analysis of data from 4,016 participants in the Folic Acid for Vascular Outcome Reduction in Transplantation trial to assess CVD and factors in renal transplant recipients.

The researchers found that 20 percent of participants had prior CVD, and the mean eGFR was 49 mL/min/1.73 m². Over a median of 3.8 years, the researchers identified a total of 527 CVD events in 3,676 participants for whom complete data were available. For those with eGFR values below 45 mL/min/1.73 m², for every 5 mL/min/1.73 m² increase in eGFR, the risk of CVD and death was 15 percent lower (hazard ratio, 0.85 for both), after adjustment. No association was found for those with an eGFR above 45 mL/min/1.73 m².

"In conclusion, in stable , lower eGFR is independently associated with adverse events, suggesting that reduced kidney function itself rather than preexisting comorbidity may lead to CVD," the authors write.

PamLab provided the high- and low-dose multivitamins used in the study.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

'Face time' for the heart diagnoses cardiac disease

10 hours ago

To the careful observer, a person's face has long provided insight into what is going on beneath the surface. Now, with the assistance of a web camera and software algorithms, the face can also reveal whether or not an individual ...

Pay-for-performance not found to impact access to CABG

Aug 27, 2014

(HealthDay)—For patients with acute myocardial infarction (AMI), treatment at pay-for-performance (P4P) hospitals is not associated with a change in the rate of coronary artery bypass graft (CABG) surgery, ...

User comments